Targeting pathological B cell receptor signalling in lymphoid malignancies
1Metabolism Branch, Center for Cancer Research, National Cancer Institute, US National Institutes of Health, Bethesda, Maryland 20892, USA.
Nature Reviews. Drug Discovery
|March 2, 2013
Summary
B cell receptor (BCR) signaling drives lymphoma growth and survival. Targeting BCR pathway effectors shows promise in clinical trials for treating various lymphoma types.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- B cell receptor (BCR) signaling is crucial for normal B cell development and function.
- Malignant B cells hijack BCR signaling pathways for proliferation and survival.
- Recent evidence confirms BCR signaling's role in human lymphoma.
Purpose of the Study:
- To review the role of BCR signaling in lymphoma.
- To highlight antigen-dependent and independent signaling in lymphoma subtypes.
- To discuss therapeutic strategies targeting the BCR pathway.
Main Methods:
- Review of existing literature on BCR signaling in lymphoma.
- Analysis of studies implicating BCR signaling in B cell malignancies.
- Examination of clinical trial data for BCR-targeted therapies.
Main Results:
- BCR signaling, both antigen-dependent and tonic, is implicated in various lymphoma subtypes.
- Direct evidence for BCR signaling in human lymphoma has recently emerged.
- Therapeutic agents targeting BCR pathway effectors demonstrate initial success in clinical trials.
Conclusions:
- BCR signaling is a key driver in the pathogenesis of many lymphomas.
- Targeting the BCR signaling pathway represents a promising therapeutic avenue for lymphoma treatment.
- Further research into BCR signaling mechanisms can lead to novel treatment strategies.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...